Mandate

Vinge advises Irisity AB (publ)

November 10, 2018 Capital Markets and Public M&A

Vinge has advised Irisity AB (publ), Nasdaq First North, in connection with a directed new issue of shares to Nordic institutional and private investors.

The subscription price of SEK 17.50 has been determined through a so called accelerated book building process. Irisity will receive approximately MSEK 25 as a result of the issue. The issue proceeds will be used, among other things, for Irisity’s development and accelerated growth by strengthening the organization through the recruitment of personnel, which can occur both through new employment and acquisition of companies with the requisite competence and thereby increasing the company’s financial flexibility and freedom of action for continued growth creation. SEB acted as financial adviser.

Vinge’s team primarily consisted of responsible partner Anders Strid, Frida Bergqvist, Wibeke Sorling and corporate assistant Camilla Andersson.

Related

Vinge advises Axcel and Sanviva on the acquisitions of DermaCura and YourRad

Vinge has advised Axcel Elevate I and Sanviva in connection with the acquisitions of DermaCura and YourRad.
September 07, 2026

Vinge advises Revivo Group on the acquisition of Premator

Revivo Group AB has acquired all the shares in Premator AB, the parent company of a group operating in the field of advanced surface treatment with extensive experience in shot blasting, anti-corrosion painting and related services. Operations are conducted in Sweden, Norway and Denmark.
September 03, 2026

Vinge advises the sellers on the sale of Nextory to Bonnier Books

Vinge has acted as legal adviser to the sellers in connection with Bonnier Books’ acquisition of Nextory, one of Europe’s leading streaming services for audiobooks and e-books. Bonnier Books is acquiring all shares in Nextory, and the transaction comprises Nextory’s operations in Sweden and internationally. The acquisition is a cash transaction and the parties have agreed not to disclose the purchase price. The transaction is subject to customary regulatory approvals.
September 02, 2026